Eloxx Pharmaceuticals Inc
Follow $ELOX
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $ELOX by emailVeridion Score
BETAMEDIUM CONF · 5 of 6 factors measuredHighest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is ELOX moving today?
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
ELOX overview
Related filings and maps
Congress activity in ELOX
No receipt-qualified Congressional disclosure is present for ELOX in the cached public ledger.
ELOX contract awards, year to date.
Public federal awards linked to this ticker.
ELOX lobbying filings, year to date.
Registered lobbying filings matched to Eloxx Pharmaceuticals Inc.